Back to results
CompletedPhase 1

Safety Study of Erythropoietin (EPO) in Parkinson's Disease

NCT01010802

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Clinic of Movement Disorders, International Center for Neurological Restoration

Havana, Cuba

View on ClinicalTrials.gov
Safety Study of Erythropoietin (EPO) in Parkinson's Disease — TrialFind